Antitoxin Export Market Intelligence: India's 45 Suppliers Shipping to 80 Countries — TransData Nexus 2026

Q: Who are the top antitoxin exporters from India?

The top antitoxin exporters from India are: 1. VINS BIOPRODUCTS LIMITED — $8.6M (64.7% market share); 2. PREMIUM SERUMS AND VACCINES PRIVATE LIMITED — $1.4M (10.1% market share); 3. SERUM INSTITUTE OF INDIA PRIVATE LIMITED — $999.9K (7.5% market share); 4. BIOLOGICAL E. LIMITED — $805.0K (6.0% market share); 5. VINS BIOPRODUCTS LTD — $373.1K (2.8% market share). Together they account for 91.1% of India's total antitoxin export value.

Q: What is the total export value of antitoxin from India?

The total export value of antitoxin from India is $13.3M USD, recorded across 524 shipment transactions from 45 active exporters to 80 destination countries. The average shipment value is $25.5K.

Q: Which countries import antitoxin from India?

India exports antitoxin to 80 countries worldwide. The top importing countries are: FRANCE (30.9% share, $4.1M), MOROCCO (11.4% share, $1.5M), UNITED ARAB EMIRATES (7.5% share, $997.7K), SUDAN (7.3% share, $969.5K), INDONESIA (5.4% share, $715.2K). These five markets account for 62.3% of total export value.

Q: What is the HS code for antitoxin exports from India?

The primary HS code for antitoxin exports from India is 30021220. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of antitoxin exports from India?

The average unit price for antitoxin exports from India is $15.43 USD per unit, with prices ranging from $0.00 to $102.72 depending on formulation, packaging, and order volume. The total market is valued at $13.3M across 524 shipments.

Q: Which ports handle antitoxin exports from India?

The primary ports for antitoxin exports from India are SAHAR AIR CARGO ACC (INBOM4) (23.9% of shipments), HYDERABAD ACC (INHYD4) (18.9% of shipments), HYDERABAD AIR (16.6% of shipments), SAHAR AIR (14.1% of shipments), Bombay Air (6.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of antitoxin?

India is one of the world's leading exporters of antitoxin due to its large base of 45 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports antitoxin to 80 countries, demonstrating 41% global market coverage.

Q: What certifications do Indian antitoxin exporters need?

Indian antitoxin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import antitoxin from India?

There are 238 registered buyers importing antitoxin from India, spread across 80 countries. The repeat buyer rate is 42.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top antitoxin supplier from India?

VINS BIOPRODUCTS LIMITED is the leading antitoxin exporter from India with a market share of 64.7% and total export value of $8.6M across 206 shipments. The top 5 suppliers together control 91.1% of total export value.

Suresh Sormare

Antitoxin

India Pharmaceutical Trade Intelligence

$13.3M45 Suppliers80 CountriesHS 30021220

ExportsIndia → FRANCE30.9%India → MOROCCO11.4%

ImportsCHINA → India$1.9M INDONESIA → India$984

#1 Supplier: VINS BIOPRODUCTS

Antitoxin Export Analysis | Transdata Nexus | TransData Nexus

How India Exports Antitoxin to the World

Between 2022 and 2026, India exported $13.3M worth of antitoxin across 524 verified shipments to 80 countries — covering 41% of world markets. The largest destination is FRANCE (30.9%). VINS BIOPRODUCTS LIMITED leads with a 64.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30021220

Antitoxin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Antitoxin export data snapshot — $13.3M · 45 exporters · 80 countriesTransData Nexus · Indian Customs Data

Top Antitoxin Exporters from India

45 active exporters · Ranked by export value

View all 45 →

Top Antitoxin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	VINS BIOPRODUCTS LIMITED	$8.6M	206	37	64.7%
2	PREMIUM SERUMS AND VACCINES PRIVATE LIMITED

Top Countries Importing Antitoxin from India

80 destination markets · Ranked by import value

All 80 countries →

Top Countries Importing Antitoxin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	FRANCE	$4.1M	30.9%
2	MOROCCO	$1.5M	11.4%
3	UNITED ARAB EMIRATES	$997.7K	7.5%
4	SUDAN	$969.5K	7.3%
5	INDONESIA	$715.2K	5.4%
6	ALGERIA	$494.1K	3.7%
7	SENEGAL	$425.5K	3.2%
8	JORDAN	$421.1K	3.2%
9	COTE D IVOIRE	$404.0K	3.0%
10	GHANA	$247.1K	1.9%

FRANCE is India's largest antitoxin export destination, absorbing 30.9% of total exports worth $4.1M. The top 5 importing countries — FRANCE, MOROCCO, UNITED ARAB EMIRATES, SUDAN, INDONESIA — together account for 62.3% of India's total antitoxin export value. The remaining 75 destination countries collectively receive the other 37.7%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Antitoxin to India?

4 origin countries · Total import value: $1.9M

India imports antitoxin from 4 countries with a combined import value of $1.9M. The largest supplier is CHINA ($1.9M, 6 shipments), followed by INDONESIA and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Antitoxin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CHINA	$1.9M	6	99.9%
2	INDONESIA	$984	2	0.1%
3	UNITED KINGDOM	$389	1	0.0%
4	SPAIN	$3	1	0.0%

CHINA is the largest supplier of antitoxin to India, accounting for 99.9% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Antitoxin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Antitoxins, classified under HS Code 30021220, are biological products regulated by the U.S. Food and Drug Administration (FDA) under the Public Health Service Act. As such, they are not listed in the FDA's Orange Book, which primarily catalogs small molecule drugs approved under the Federal Food, Drug, and Cosmetic Act. Consequently, there are no Abbreviated New Drug Applications (ANDAs) for antitoxins. Instead, manufacturers seeking to market antitoxins in the U.S. must submit a Biologics License Application (BLA) to the FDA's Center for Biologics Evaluation and Research (CBER). This process involves comprehensive evaluations of safety, purity, and potency.

Given the specialized nature of antitoxins and the stringent regulatory requirements, the number of Indian exporters entering the U.S. market is limited. This is reflected in the data, which shows that the United States is not among the top five destination countries for Indian antitoxin exports. The primary markets include France (30.9%), Morocco (11.4%), the United Arab Emirates (7.5%), Sudan (7.3%), and Indonesia (5.4%).

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), antitoxins are classified as biological medicinal products. To market these products, manufacturers must obtain a Marketing Authorization (MA) from the European Medicines Agency (EMA) or the UK's Medicines and Healthcare products Regulatory Agency (MHRA). The authorization process requires adherence to Good Manufacturing Practice (GMP) standards, ensuring product quality and safety.

France, accounting for 30.9% of Indian antitoxin exports, exemplifies the significance of the EU market for Indian manufacturers. Compliance with EMA regulations and GMP standards is essential for maintaining and expanding market presence in these regions.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) includes certain antitoxins in its Model List of Essential Medicines, recognizing their critical role in treating specific toxin-mediated conditions. Inclusion in this list underscores the global importance of these products. Additionally, antitoxins must comply with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to ensure consistent quality and efficacy.

4India Regulatory Classification

In India, antitoxins are classified under Schedule H of the Drugs and Cosmetics Rules, indicating that they are prescription-only medicines. The National Pharmaceutical Pricing Authority (NPPA) has set ceiling prices for certain antitoxins to ensure affordability. For instance, the ceiling price for Diphtheria Antitoxin Injection (10,000 IU/pack) was set at ₹1,229.06 per pack as per the notification dated April 28, 2014. Manufacturers intending to export antitoxins must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with export regulations.

5Patent & Exclusivity Status

The patent landscape for antitoxins varies depending on the specific product and its formulation. Generally, many traditional antitoxins are off-patent, allowing for generic competition. However, newer formulations or manufacturing processes may still be under patent protection, restricting generic entry until patent expiration.

6Recent Industry Developments

In December 2025, the NPPA fixed retail prices for 37 new drug formulations under the Drugs (Prices Control) Order (DPCO), 2013, covering a wide range of commonly used medicines, including those for hypertension, diabetes, respiratory disorders, allergies, and mental health conditions.

In November 2025, the NPPA notified ceiling prices for six scheduled formulations under the DPCO, 2013, including Riboflavin Tablets (10 mg), Peritoneal Dialysis Solution, Ethyl Alcohol (Denatured) 70%, and Human Normal Immunoglobulin solutions (5%, 10%, 16.5%).

In April 2025, the NPPA revised the ceiling prices of six scheduled formulations, including acetyl salicylic acid, calcium carbonate, dapsone, medroxy progesterone acetate, and rifampicin, to ensure affordability and accessibility.

These regulatory actions reflect the Indian government's commitment to ensuring the affordability and accessibility of essential medicines, including antitoxins, both domestically and for export markets.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Antitoxin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including antitoxin production, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70% of APIs used in Indian manufacturing are sourced from China, underscoring a significant dependency on Chinese suppliers for critical raw materials. This reliance exposes the supply chain to vulnerabilities stemming from geopolitical tensions, trade disputes, and regulatory changes in China.

Recent disruptions have highlighted these risks. In February 2025, the U.S. Food and Drug Administration (FDA) issued warning letters to API manufacturers in China and India for significant deviations from current Good Manufacturing Practice (cGMP) standards, including quality control failures and data integrity issues. Such regulatory actions can lead to supply interruptions, affecting the availability of essential medicines like antitoxins.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration in India's antitoxin exports. The top five exporters account for 91.1% of the total export value, with VINS BIOPRODUCTS LIMITED alone contributing 64.7%. This concentration poses a significant single-source risk; any operational or compliance issues within these key suppliers could disrupt the entire supply chain.

Access Complete Antitoxin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 524 transactions across 80 markets.

Request Demo View Pricing

Frequently Asked Questions — Antitoxin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top antitoxin exporters from India?

The leading antitoxin exporters from India are VINS BIOPRODUCTS LIMITED, PREMIUM SERUMS AND VACCINES PRIVATE LIMITED, SERUM INSTITUTE OF INDIA PRIVATE LIMITED, and 11 others. VINS BIOPRODUCTS LIMITED leads with 64.7% market share ($8.6M). The top 5 suppliers together control 91.1% of total export value.

What is the total export value of antitoxin from India?

The total export value of antitoxin from India is $13.3M, recorded across 524 shipments from 45 active exporters to 80 countries. The average shipment value is $25.5K.

Which countries import antitoxin from India?

India exports antitoxin to 80 countries. The top importing countries are FRANCE (30.9%), MOROCCO (11.4%), UNITED ARAB EMIRATES (7.5%), SUDAN (7.3%), INDONESIA (5.4%), which together account for 62.3% of total export value.

What is the HS code for antitoxin exports from India?

The primary HS code for antitoxin exports from India is 30021220. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Antitoxin

Antitoxin

How India Exports Antitoxin to the World

Top Antitoxin Exporters from India

Top Countries Importing Antitoxin from India

Who Supplies Antitoxin to India?

Quick Facts

Related Products

Related Analysis

Need Details?

Regulatory Landscape — Antitoxin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Antitoxin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Antitoxin Trade Intelligence

Frequently Asked Questions — Antitoxin Exports from India

Who are the top antitoxin exporters from India?

What is the total export value of antitoxin from India?

Which countries import antitoxin from India?

What is the HS code for antitoxin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of antitoxin exports from India?

Which ports handle antitoxin exports from India?

Why is India a leading exporter of antitoxin?

What certifications do Indian antitoxin exporters need?

How many buyers import antitoxin from India?

What is the market share of the top antitoxin exporter from India?

Analysis Methodology